Get alerts
Pro · TeamFederal

Contracts expiring in the next 12 months

90 federal awards worth $887M end in this window (stated value $1.0M and up, parts and commodities excluded), from USAspending period-of-performance dates. Each one is a likely recompete: find the incumbent, the office and the codes, then watch for the sources sought. Look up any incumbent's full award history in the government contractor directory.

Awards ending90federal contracts
Stated value$887Mawards of $1.0M and up
Window12 monthsby period-of-performance end
Pro feature

Incumbents, values and the full list are on Pro

The five rows below show the dates and agencies. Pro ($39/mo) shows every expiring award with the incumbent name, so you can start teaming conversations a year out.

See plans
EndsIncumbent · descriptionAgency · officeNAICS · PSCValueSet-asideSource
Jun 21, 2027ProADVANCED RESEARCH AND DEVELOPMENT AND DELIVERY OF ADULT AND PEDIATRIC MIDAZOLAM AUTOINJECTORS THAT HAVE RECEIVED EMERGENOffice of Assistant Secretary for Preparedness and ResponseBARDA - ASPR / DAAPPO / BARDA DCMA541714 · AN13$104MUSAspending
Dec 31ProCLINICAL DEVELOPMENT OF CRISPR-CAS3 PHAGE COCKTAIL FOR THE TREATMENT OF RECURRENT URINARY TRACT INFECTIONS CAUSED BY ESCOffice of Assistant Secretary for Preparedness and ResponseBARDA - ASPR / DAAPPO / BARDA DCMA541714 · AN13$74MUSAspending
Sep 29, 2027ProDEVELOPMENT OF CD388 AS A LONG-LASTING PROPHYLACTIC ANTI-VIRAL OPTION FOR PROTECTION AGAINST THE HEALTH IMPACTS CAUSED BOffice of Assistant Secretary for Preparedness and Response541714 · AN14$58MUSAspending
Oct 31ProIGF::OT::IGFOffice of Assistant Secretary for Preparedness and ResponseBARDA - ASPR / DAAPPO / BARDA DCMA541714 · AN13$50MUSAspending
Dec 31ProTHIS ACQUISITION WILL ALLOW BARDA TO INVEST PROJECT BIOSHIELD FUNDS FOR LATE-STAGE CLINICAL DEVELOPMENT, REGULATORY APPROffice of Assistant Secretary for Preparedness and ResponseBARDA - ASPR / DAAPPO / BARDA DCMA541714 · AN12$45MUSAspending

Source: USAspending.gov contract awards synced nightly. "Ends" is the current period-of-performance end; an exercised option moves it. Not every expiring award is recompeted.